Additionally, enhancements in hyperlipidemia and diabetes within obese mice, mainly down‐regulation of PPAR‐γ and SREBP‐1c increased lipid metabolism in order to show beneficial effects in cholesterol levels (Zang et al. 2015). Here, SREBF1 is linked to hyperlipidemia.